Skip to content

ANI Pharmaceuticals ANIP Generics and Other — Other (expense)income , net

Similar metrics at other companies

ON Semiconductor logo
ONOther Income (Expense)
$8.8M-30.7%
EFC
EFCOther Income (Expense)
$4.48M-81.5%
MTZ
MTZOther Income (Expense)
-$3.3M-323%
MYR Group logo
MYRGOther Income (Expense)
-$948K-216%
Tempus AI, Inc. logo
TEMOther Income (Expense)
-$27.71M-0.9%
ePlus logo
PLUSOther Income - Net
$0-100%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's generics and other — other (expense)income , net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's generics and other — other (expense)income , net?
ANI Pharmaceuticals (ANIP) reported generics and other — other (expense)income , net of $0 in Q1 2026.
What does generics and other — other (expense)income , net mean?
Includes miscellaneous non-operating income or expenses that do not fit into standard categories like interest or taxes, such as foreign exchange gains or losses. It provides a view into peripheral financial events that impact the segment's overall net contribution.